Dr. Sura Surendranath Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Sura Surendranath Reddy, on behalf of the Promoter and Promoter Group of Vijaya Diagnostic Centre Limited, has submitted a declaration to the National Stock Exchange confirming that no new share encumbrances (pledges) were created during the Financial Year ended March 31, 2026. The disclosure is a regulatory requirement under SEBI's takeover regulations. Any existing encumbrances would have been separately reported through System Driven Disclosure or earlier stock exchange filings. This is a routine annual compliance filing.
Positive signal for existing shareholders as it confirms promoters have not taken on additional pledges against their shareholding, reducing the risk of forced selling pressure on the stock.